PFSA

Profusa, Inc.

OTC · Surgical & Medical Instruments & Apparatus · Inc. DE · CIK 0001859807
$0.2240 -17.65% $1.0M
Insider Buying Cluster (2 insiders)High Impact Filing (8/10)
Vol
Market Cap$1.0M
Cap SizeNano Cap
Inst. Holders5 funds
Inst. Value$19.3K
Insider Activity2B / 0S
Insider Net $$7.0T
Reddit Sentiment73° Bullish
SEC Reports3
Press Releases2
Exchange OTC·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001859807·Prev Close $0.2720

Top Institutional Holders

FundValueMove
CITADEL ADVISORS LLC$15.6K
VANGUARD CAPITAL MANAGEMENT LLC$2.0K
VANGUARD FIDUCIARY TRUST CO$859.00
MORGAN STANLEY$811.00
FMR LLC$7.00

Recent Insider Trades

DateInsiderTypeValue
May 4, 2026STOVER JACKBUY$3.5T
May 4, 2026Knechtel FredBUY$3.5T
Jan 26, 2026O'Rourke PeterJ$0.00
Jan 26, 2026O'Rourke PeterJ$0.00
Jan 26, 2026STOVER JACKJ$0.00

Reddit Sentiment

73°
Bullish
Bearish Neutral Bullish
7 mentions 5 bullish 0 bearish
5 institutional holders with $19.3K total value (38,090 shares) as of 2026-Q1. Top holders: CITADEL, VANGUARD, VANGUARD.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1CITADEL ADVISORS LLC30,844$15.6K81.0%
2VANGUARD CAPITAL MANAGEMENT LLC3,939$2.0K10.3%
3VANGUARD FIDUCIARY TRUST CO1,694$859.004.4%
4MORGAN STANLEY1,600$811.004.2%
5FMR LLC13$7.000.0%
5 unique insiders with 11 transactions. Net insider value: $7.0T ($7.0T bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 4, 2026STOVER JACK EDirectorBUY1,869,796$1,869,796.00$3.5T
May 4, 2026Knechtel Fred S.Chief Financial OfficerBUY1,869,796$1,869,796.00$3.5T
Jan 26, 2026O'Rourke PeterDirectorJ15,250
Jan 26, 2026O'Rourke PeterDirectorJ107,750
Jan 26, 2026STOVER JACK EDirectorJ380,280
Jan 26, 2026STOVER JACK EDirectorJ553,665
Jan 26, 2026Chung LaurenDirectorJ30,000
Jan 26, 2026NorthView Sponsor I, LLC10%+ OwnerJ4,743,750
Jan 26, 2026NorthView Sponsor I, LLC10%+ OwnerJ5,162,500
Jan 26, 2026Knechtel Fred S.Chief Financial OfficerJ818,961
Jan 26, 2026Knechtel Fred S.Chief Financial OfficerJ516,863

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-03-31
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2026-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

73°
Bullish
Bearish Neutral Bullish
7 mentions 5 bullish 0 bearish 5 time periods

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
Apr 6, 2026160° Warm101
Apr 6, 2026160° Warm101
Apr 6, 2026258° Warm102
Apr 6, 2026258° Warm102
Feb 22, 2026160° Warm101

Recent Reddit Threads

r/pennystocks Bullish 2mo ago
$PFSA +42% -- $30M PanOmics acquisition LOI sends Profusa flying
▲ 1 💬 1 ⚡ 0.5
r/pennystocks Neutral 2mo ago
criterias to find the ONE
▲ 1 💬 1 ⚡ 0.5
r/pennystocks Bullish 2mo ago
06 APRIL 2026 , WHAT ARE THE BIGGEST WINNERS PRE-MARKET AN WHY ?
▲ 1 💬 1 ⚡ 0.5
Jun 12, 2026
announcement
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform
<p align="justify"><b>BERKELEY, CA, June 12, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA),</b> a digital health company pioneering next-ge
May 15, 2026
announcement
Profusa Announces Listing Transfer to The Nasdaq Capital Market
<p align="justify">BERKELEY, CA, May 15, 2026 (GLOBE NEWSWIRE) --  Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a  digital health comp
May 8, 2026
other
Profusa Receives Favorable Nasdaq Listing Determination
<p align="justify">BERKELEY, CA, May 08, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a  digital health comp
May 5, 2026
other
Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value
<p>Company focusing resources on near-term commercial milestones; European CE Mark process and Healthcare Research revenue opportunities</p>
Apr 28, 2026
short_volume
Short Volume: PFSA — 58.3% short (1.1M / 1.9M)
Short: 1,079,251 | Exempt: 128,982 | TRF Vol: 1,851,328 | Short Ratio: 58.3% | Off-exchange volume (dark pool + OTC)
Apr 7, 2026
short_interest
FTD: PFSA — 837,938 shares ($1.6M) failed to deliver
Settlement: 20260407, Price: $1.85, FTD Value: $1,550,185.3, PROFUSA INC COM NEW
Apr 6, 2026
other
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform
<p align="center"><i>Company secures scalable multi-omics diagnostics platform and launches Mayo Clinic partnership adding to Lumee real-time biochemi
Apr 6, 2026
earnings_calendar
PFSA Q4 2025 Earnings Scheduled — 2026-04-06
Apr 6, 2026
short_volume
Short Volume: PFSA — 56.8% short (39.3M / 69.1M)
Short: 39,265,623 | Exempt: 349,655 | TRF Vol: 69,071,907 | Short Ratio: 56.8% | Off-exchange volume (dark pool + OTC)
Apr 2, 2026
short_volume
Short Volume: PFSA — 56.0% short (0.9M / 1.6M)
Short: 874,417 | Exempt: 3,230 | TRF Vol: 1,561,465 | Short Ratio: 56.0% | Off-exchange volume (dark pool + OTC)
Mar 23, 2026
earnings_calendar
PFSA Q4 2025 Earnings Scheduled — 2026-03-23